Osteoradionecrosis After Intensity-Modulated Radiation Therapy or Proton Therapy in Oropharyngeal Carcinoma

In this large, relatively homogeneous cohort of patients with OPSCC, proton therapy was associated with a higher rate of ORN compared with IMRT, particularly in the definitive setting, although high-grade ORN remained uncommon across both modalities. These retrospective findings should be considered exploratory and underscore the need for future hypothesis-driven studies to refine dose constraints and optimize treatment planning to mitigate ORN risk among patients with OPSCC.

Authors

Institutions

Publication Details

Journal
JAMA Otolaryngology–Head & Neck Surgery
Published
2025-11-26
DOI
https://doi.org/10.1001/jamaoto.2025.4179
Citations
3
Primary Topic
Oral health in cancer treatment
Type
article
Field-Weighted Citation Impact
4.56
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Osteoradionecrosis After Intensity-Modulated Radiation Therapy or Proton Therapy in Oropharyngeal Carcinoma

Annu Singh, SaeHee K. Yom, Sean Matthew McBride, Daphna Y. Gelblum et al.
3 citations
JAMA Otolaryngology–Head & Neck Surgery
Oral health in cancer treatment
4.56
article

Osteoradionecrosis After Intensity-Modulated Radiation Therapy or Proton Therapy in Oropharyngeal Carcinoma

Annu Singh, SaeHee K. Yom, Sean Matthew McBride, Daphna Y. Gelblum, Kevin Sine, Cherry L. Estilo, Jennifer R. Cracchiolo, Kaveh Zakeri, Nadeem Riaz, Haibo Lin, Yao Yu, Alan Loh Ho, Nancy Y. Lee, Edward Christopher Dee, Teeradon Treechairusame, Joseph M. Huryn, Eric Jeffrey Sherman, Marc A. Cohen, Richard J. Wong, C. Jillian Tsai, Achraf A. Shamseddine, Jung Julie Kang, Dennis Mah, James O. Suggitt, Zhigang Zhang, Yingzhi Wu, Fan Yang, Linda Chen, Andy Shim, Ian Ganly, Elizabeth Silverio Polanco, Arya Honawar
article en
3 citations

Abstract

In this large, relatively homogeneous cohort of patients with OPSCC, proton therapy was associated with a higher rate of ORN compared with IMRT, particularly in the definitive setting, although high-grade ORN remained uncommon across both modalities. These retrospective findings should be considered exploratory and underscore the need for future hypothesis-driven studies to refine dose constraints and optimize treatment planning to mitigate ORN risk among patients with OPSCC.

JAMA Otolaryngology–Head & Neck SurgeryVol. 152(2)
University Health Network (CA), Siriraj Hospital (TH), Memorial Sloan Kettering Cancer Center (US), Cornell University (US), Mahidol University (TH), Princess Margaret Cancer Centre (CA), Yale University (US), Presbyterian Hospital (US), New York Proton Center (US), ProCure (United States) (US), Michigan State University (US)
Openalex Percentile: Top 5%
Oral health in cancer treatment
4.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.